Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1893-1902

  Mehta, Reeta T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CLOFAZIMINE; DIMETHYL SULFOXIDE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; LIPOSOME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG TARGETING; ENCAPSULATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0029800027     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1893     Document Type: Article

References (61)

1. Alving, C. R. 1983. Delivery of liposome encapsulated drugs to macrophages. Pharmacol. Ther. 22:407-424.
2. Ashtekar, D., N. Duzgunes, and P. R. J. Gangadharam. 1991. Activity of free and liposome encapsulated streptomycin against Mycobacterium-avium complex (MAC) inside peritoneal macrophages. J. Antimicrob. Chemother. 28: 615-617.
3. Bermudez, L., and L. S. Young. 1987. Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages. J. Med. Biol. Res. 20:191-201.
4. Bermudez, L. E., M. Wu, and L. S. Young. 1987. Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. J. Infect. Dis. 156:510-513.
5. Bermudez, L. E., A. O. Yau-Young, J. P. Lin, J. Cogger, and L. S. Young. 1990. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. J. Infect. Dis. 161: 1262-1268.
6. Bonventre, P., and G. Gregoriadis. 1978. Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob. Agents Chemother. 13:1049-1051.
7. Carlson, G. A., S. T. Marshall, and A. T. Truesdale. 1984. Adaptive immune defects and delayed rejection of allogeneic tumor cells in beige mice. Cell. Immunol. 87:348-356.
8. Cynamon, M. H., C. E. Swenson, G. S. Palmer, and R. S. Ginsberg. 1989. Liposome-encapsulated amikacin therapy of Mycubacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 33:1179-1183.
9. David, H. L., S. Clavel-Seres, F. Clement, and K. S. Goh. 1987. Uptake of selected antibacterial agents in Mycobacterium avium. Zentralbl. Bakteriol. Mikrobiol. Hyg. Reihe A 265:385-392.
10. Dayan Sandler, E., V. L. Ng, and W. K. Hadley. 1992. Clofazimine crystals in alveolar macrophages from a patient with the acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 116:541-543.
11. Duzgunes, N., D. R. Ashtekar, D. L. Flasher, N. Ghori, R. J. Debs, D. S. Friend, and P. R. J. Gangadharam. 1991. Treatment of Mycobacterium avium intracellulare complex infection in beige mice with free and liposome encapsulated streptomycin: role of liposome type and duration of treatment. J. Infect. Dis. 164:143-151.
12. Duzgunes, N., V. K. Perumal, L. Kesavalu, J. A. Goldstein, R. J. Debs, and P. R. J. Gangadharam. 1988. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex in beige mice. Antimicrob. Agents Chemother. 32:1404-1411.
13. Edmondson, J. M., L. S. Armstrong, and A. O. Martinez. 1988. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. J. Tissue Culture Methods 11:15-17.
14. Elin, R. J., J. B. Edelin, and S. M. Wolff. 1974. Infection and immunoglobulin concentrations in chediak-Higashi mice. Infect. Immun. 10:88-91.
15. Emmen, F., and G. Storm. 1987. Liposomes in the treatment of infectious diseases. Pharm. Weekbl. Sci. Ed. 9:162-171.
16. Fauci, A. S. 1984. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Intern. Med. 100:92-106.
17. Forster, D. J., D. M. Causey, and N. A. Rao. 1992. Bull's eye retinopathy and clofazimine. Ann. Intern. Med. 116:876-877.
18. Fountain, M. W., M. Dees, and C. R. Schultz. 1981. Enhanced intracellular killing of Staphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin, and tobramycin. Curr. Microbiol. 6:373.
19. Gallin, J. I., J. S. Bujak, E. Patten, and S. M. Wolff. 1974. Granulocyte function in the Chediak-Higashi syndrome of mice. Blood 43:201-206.
20. Gangadharam, P. R. J. 1986. Animal models for nontuberculosis mycobacterial diseases, p. 1-94. Experimental models in antimicrobial chemotherapy, vol. 3. Academic Press Inc., London.
21. Gangadharam, P. R. J. 1995. Beige mouse model for Mycobacterium avium complex disease. Antimicrob. Agents Chemother. 39:1647-1654.
22. Gangadharam, P. R. J., D. A. Ashtekar, D. L. Flasher, and N. Duzgunes. 1995. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob. Agents Chemother. 39:725-730.
23. Gangadharam, P. R. J., D. A. Ashtekar, N. Ghori, J. A. Goldstein, R. J. Debs, and N. Duzgunes. 1991. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J. Antimicrob. Chemother. 28:425-435.
24. Gangadharam, P. R. J., C. K. Edwards, P. S. Murthy, and P. F. Pratt. 1983. An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. Am. Rev. Respir. Dis. 127:648-664.
25. Gangadharam, P. R. J., and M. D. Iseman. 1986. Antimycobacterial drugs, p. 17-39. In P. K. Peterson and J. Verhoel (ed.), Antimicrobial agents annual 1. Elsevier Science Publishers, Amsterdam.
26. Gangadharam, P. R. J., and M. D. Iseman. 1987. Antimycobacterial drugs, p. 14-35. In P. K. Peterson and J. Verhoel (ed.), Antimicrobial agents annual 2. Elsevier Science Publishers, Amsterdam.
27. Gomez-Flores, R., S. Gupta, R. Tamez-Guerra, and R. T. Mehta. 1995. Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J. Clin. Microbiol. 33:1842-1846.
28. Green, J. B., G. S. Sidhu, S. Lewin, J. F. Levine, H. Masur, M. S. Simberkoff, P. Nicholas, R. C. Good, S. D. Zolla-Pazner, A. A. Pollack, M. L. Tapper, and R. S. Holzman. 1982. Mycobacterium avium-intracellulare: a case of disseminated life-threatening infection in homosexuals and drug abusers. Ann. Intern. Med. 97:539-546.
29. Gregoriadis, G. (ed.). 1984. Liposome technology. CRC Press, Inc., New York.
30. Holdiness, M. R. 1989. Clinical pharmacokinetics of clofazimine. Clin. Pharmacokinet. 16:74-85.
31. Irma, A., J. M. Woudenberg, and F. H. Roerdink. 1986. Antimicrobial chemotherapy directed by liposomes. J. Antimicrob. Chemother. 17:547-552.
32. Kirkpatrick, C. E., and J. P. Farrell. 1982. Leishmaniasis in beige mice. Infect. Immun. 38:1208-1216.
33. Lane, P. W., and E. D. Murphy. 1972. Susceptibility to spontaneous pneumonitis in an inbred strain of beige and satin mice. Genetics 72:451-460.
34. Le Conte, P., F. Le Gallou, G. Potel, L. Struillou, D. Baron, and H. B. Drugeon. 1994. Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob. Agents Chemother. 38:2695-2701.
35. Lopez-Berestein, G., G. P. Bodey, L. S. Frankel, and K. Mehta. 1987. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. J. Clin. Oncol. 5:310-317.
36. Lopez-Berestein, G., V. Fainstein, R. L. Hopfer, M. P. Sullivan, M. Keating, M. G. Rosenblum, K. Mehta, R. Mehta, M. Luna, E. M. Hersh, J. Reuben, and R. Juliano. 1985. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 151:704-710.
37. Lopez-Berestein, G., M. G. Rosenblum, and R. T. Mehta. 1984. Altered tissue distribution of amphotericin B by liposome encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv. 1:199-205.
38. Mehta, R., G. Lopez-Berestein, R. L. Hopfer, K. Mills, and R. Juliano. 1984. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim. Biophys. Acta 770:230-234.
39. Mehta, R. T. 1989. Liposomes as drug carriers for polyene antibiotics. Adv. Drug Deliv. Rev. 3:283-306.
40. 39a. Mehta, R. T. 1994. Reduced toxicity and improved antimycobacterial activity of liposome-entrapped clofazimine in beige mouse model, abstr. U-107, p. 191. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
41. Mehta, R. T., R. L. Hopfer, L. A. Gunner, R. L. Juliano, and G. Lopez-Berestein. 1987. Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrob. Agents Chemother. 31:1897-1900.
42. Mehta, R. T., A. Keyhani, T. McQueen, B. Rosenbaum, K. V. Rolston, and J. J. Tarrand. 1993. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob. Agents Chemother. 37:2584-2587.
43. Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1991. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. J. Infect. Dis. 164:1003-1006.
44. Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1994. Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. Chemotherapy (Basel) 40:256-264.
45. Mehta, R. T., K. Mehta, G. Lopez-Berestein, and R. L. Juliano. 1985. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect. Immun. 47:429-433.
46. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
47. Pedroso de Lima, M. C., B. H. Chiche, R. J. Debs, and N. Düzgünes. 1990. Interaction of antimycobacterial and anti-pneumocystis drugs with phospholipid membranes. Chem. Phys. Lipids 53:361-371.
48. Peters, J. H., K. J. Hamme, and G. R. Gordon. 1982. Determination of clofazimine in plasma by high-performance liquid chromatography. J. Chromatogr. 229:503-508.
49. Poznansky, M. J., and R. L. Juliano. 1984. Biological approaches to the controlled delivery of drugs: a critical review. Pharm. Rev. 36:277-336.
50. Roder, J. C. 1979. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J. Immunol. 123:2168-2173.
51. Saito, H., and H. Tomioka. 1989. Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother. 33:429-433.
52. Saxena, R. K., Q. B. Saxena, and W. H. Adler. 1982. Defective T-cell response in beige mutant mice. Nature (London) 295:240-241.
53. Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA 78:5104-5108.
54. Stevenson, M., A. Baillie, and R. Richards. 1983. Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in J774 macrophage cell line mediated by liposome delivery. Antimicrob. Agents Chemother. 24:742-748.
55. Swenson, C. R., M. C. Popescu, and R. S. Ginsberg. 1988. Preparation and use of liposomes in the treatment of microbial infections. Crit. Rev. Microbiol. 15:S1-S31.
56. Tadakuma, T., N. Ikewak, T. Yasuda, M. Tsutsumi, S. Saito, and K. Saito. 1985. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrob. Agents Chemother. 28:28-35.
57. Tomiyoka, H., H. Saito, K. Sato, and T. Yoneyama. 1991. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Am. Rev. Respir. Dis. 144:575-579.
58. Vladimirsky, M. A., and G. A. Ladigina. 1982. Antibacterial activity of liposome-entrapped streptomycin in mice infected with Mycobacterium tuberculosis. Biomedicine 36:375-377.
59. Wichert, B. V., R. J. Gonzalez-Rothi, L. E. Straub, B. M. Wichert, and H. Schreier. 1992. Amikacin liposomes - characterization, aerosolization, and in vitro activity against Mycobacterium avium-intracellulare in alveolar macrophages. Int. J. Pharm. 78:2-3.
60. Young, L. S., C. B. Inderlied, O. G. Berline, and M. S. Gottlieb. 1986. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev. Infect. Dis. 8:1024.
61. Zakowski, P., S. Fligiel, G. W. Berline, and L. Johnson, Jr. 1982. Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 248:2980-2982.